This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the use of Thermo Fisher's Placental Growth Factor (PlGF) plus and soluble FMS-like tyrosine kinase-1 receptor (sFlt-1) assays for diagnosing pre-eclampsia.

Ticker(s): TMO

Who's the expert?

Institution: Jamaica Hospital 

  • Associate Ob/Gyn Residency Director at Jamaica Hospital
  • Sees 40 patients with active and chronic VVC
  • Currently prescribes Brexafemme to 15 patients

Interview Goal
to discuss the current diagnosis methods and the use of Thermo Fisher's Placental Growth Factor (PlGF) plus and soluble FMS-like tyrosine kinase-1 receptor (sFlt-1) assays for detecting pre-eclampsia in pregnant women.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.